Triptolide suppresses proinflammatory cytokine-induced matrix metalloproteinase and aggrecanase-1 gene expression in chondrocytes

This publication has 39 references indexed in Scilit:

• Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription
  Arthritis & Rheumatism, 2004
• PATHWAYS BY WHICH INTERLEUKIN 17 INDUCES ARTICULAR CARTILAGE BREAKDOWN IN VITRO AND IN VIVO
  Cytokine, 2001
• The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation
  Osteoarthritis and Cartilage, 2001
• PG490-88, a Derivative of Triptolide, Blocks Bleomycin-Induced Lung Fibrosis
  The American Journal of Pathology, 2001
• Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-jun N-terminal kinase, and nuclear factor κB: Differential regulation of collagenase 1 and collagenase 3
  Arthritis & Rheumatism, 2000
• Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis
  Arthritis & Rheumatism, 1999
• Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κB
  Journal of Biological Chemistry, 1998
• The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis.
  Journal of Clinical Investigation, 1996
• Degradation of cartilage aggrecan by collagenase‐3 (MMP‐13)
  FEBS Letters, 1996
• Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.
  Journal of Clinical Investigation, 1996